Abstract:Abstract Introduction Excessive daytime sleepiness (EDS) is a prevalent condition estimated to affect up to 33% of the United States population. EDS is a heterogeneous and complex symptom of various sleep disorders, insufficient sleep, and other chronic conditions and medications. EDS has also been associated with increased risk of cardiovascular and neuropsychiatric diseases, potentially through bidirectional causal pathways. In this study, we used metabolomic measurements in 6071 individuals from the Hispanic Community Health Study/Study of Latinos to elucidate the metabolomic factors associated with EDS. Methods EDS was assessed using the Epworth Sleepiness Score (a 24-point scale) at baseline (2008), continuously modeled. Metabolomics (877 metabolites) were quantified using the Metabolon platform—from blood assayed at baseline—and were log scaled. Our primary and sex stratified models adjusted for age, body mass index, ethnicity, recruitment center, alcohol, smoking, and physical activity. Secondary analysis further adjusted for insomnia, sleep duration, and sleep apnea. Significance threshold was set to 0.00013 to account for multiple testing. Finally, the interplay between metabolites, pathways, and genes was investigated through network and pathway enrichment analyses. Results Levels of seven metabolite were each associated with a decrease of the sleepiness score by approximately 0.4 points per one log unit increase in metabolite levels. Those metabolites were primarily categorized as fatty acids (Eicosadienoic acid, Docosadienoate), steroids (Pregnenolone sulphate, Tetrahydrocortisol-glucuronide), along with a sphingomyelin and two uncharacterized metabolites. Sex stratified analysis identified three additional metabolites associated with EDS in men: Tyramine O-sulfate and two phosphatidylcholines. Tyramine O-sulfate was particularly associated with an increased sleepiness score by 0.5 per log unit; with attenuation after adjusting for sleep traits. Network and pathway enrichment analysis indicated that changes in pathways related to cortisol metabolism, hormonal steroid metabolism, and melatonin metabolism were linked to EDS. Conclusion These results suggest that a combination of metabolomic factors, representing diet and steroid hormonal pathways dietary related metabolites, and some genetic factors contributes to the metabolic profile of EDS. Some associations appeared independent of common sleep disorders while a male-specific association was driven by sleep disturbances (insomnia). Support (if any) NIH R01HL153814 (to H.W.), R01HL161012 (to T.S.), and R35HL135818 (to SR).

Steroid Hormone Biosynthesis and Dietary Related Metabolites associated with Excessive Daytime Sleepiness

0032 Metabolomic Profile of Excessive Daytime Sleepiness in the Hispanic Community Health Study/Study of Latinos

Clinical Features and Correlates of Excessive Daytime Sleepiness in Parkinson's Disease

Understanding and approaching excessive daytime sleepiness

Untargeted Metabolome Atlas for Sleep Phenotypes in the Hispanic Community Health Study/Study of Latinos

Evaluating pharmacological treatments for excessive daytime sleepiness in obstructive sleep apnea: A comprehensive network meta-analysis and systematic review

0882 The Association Between Objective Daytime Sleepiness and Glucose Metabolism in OSA Patients: A Metabolomics Study

Serum metabolic alterations in peritoneal dialysis patients with excessive daytime sleepiness

Investigation of causal effects of blood metabolites on insomnia and circadian rhythm sleep wake disorders

A Large-Scale Genome-Wide Gene-Sleep Interaction Study in 732,564 Participants Identifies Lipid Loci Explaining Sleep-Associated Lipid Disturbances

Clinical Features and Contributing Factors of Excessive Daytime Sleepiness in Chinese Obstructive Sleep Apnea Patients: The Role of Comorbid Symptoms and Polysomnographic Variables.

Gene-Excessive Sleepiness Interactions Suggest Treatment Targets for Obstructive Sleep Apnea Subtype

Obstructive Sleep Apnea With or Without Excessive Daytime Sleepiness: Clinical and Experimental Data-Driven Phenotyping

Constructing Prediction Models for Excessive Daytime Sleepiness by Nomogram and Machine Learning: A Large Chinese Multicenter Cohort Study

Assessment of vitamin D, exercise, and lipid profile associated with excessive daytime sleepiness in school children

The association of objective daytime sleepiness with impaired glucose metabolism in patients with obstructive sleep apnea: a multi-omics study

Longitudinal Evolution and Plasma Biomarkers for Excessive Daytime Sleepiness in Parkinson's Disease

Polysomnographic characteristics of excessive daytime sleepiness phenotypes in obstructive sleep apnea: results from the international sleep apnea global interdisciplinary consortium

[An Analysis of Clinical Characteristics and Factors in Parkinson's Disease Patients with Excessive Daytime Sleepiness].

Socioeconomic Position and Excessive Daytime Sleepiness: A Systematic Review of Social Epidemiological Studies

Excessive Daytime Sleepiness and Associated Factors in Patients with Type 2 Diabetes Mellitus: a Cross-Sectional Study